Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics and Pharmacokinetics of GP40141 vs Nplate in Healthy Volunteers
NCT05652595Phase 1Unknown
- Sponsor
- Geropharm
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of romiplostim in immune thrombocytopenia (ITP) (2 arms), sponsored by Geropharm. Primary endpoints: Area Under the Platelet Count Time Curve and Maximum Platelet Count. Status: unknown.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05652595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05652595.